BAY-8400
BAY-8400 is an orally active, potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (IC50=81 nM) . BAY-8400 can be used for the research of cancer[1].
Product Specifications
CAS Number
2763602-59-9
UNSPSC
12352005
Target
DNA-PK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bay-8400.html
Concentration
10mM
Purity
99.38
Solubility
DMSO : 62.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC(C1=CC(C2=CC=C3N=CC4=NN=C(N4C3=C2)C5=CCCOCC5)=CN=C1)F
Molecular Formula
C21H17F2N5O
Molecular Weight
393.39
References & Citations
[1]Berger M, et al. BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies [published online ahead of print, 2021 Aug 24]. J Med Chem. 2021;10.1021/acs.jmedchem.1c00762.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030451 100 µg
Recombinant SARS-CoV-2 Spike RBD (E471Q) (His Tag)
Sign In for Pricing
View Details 
BNC400172-500 1x 500 µL
CD45 / LCA (135-4C5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details